PharmaShots | Incisive News in 3 Shots

Subscribe Now

Regor

Genentech Reports the Acquisition of Regor's CDK Inhibitors Portfolio Targeting Breast Cancer

Genentech Reports the Acquisition of Regor's CDK Inhibitors Portfolio Targeting Breast Cancer

September 30, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us